PRESS-RELEASE ·Filed Oct 16, 2026
Press release · Activist
Actionable Insight • Neutral
Routine inducement grant with no immediate trading signal. Monitor upcoming clinical catalysts for obexelimab and orelabrutinib for material stock-moving events.
Latest settled — T+5d
ZBIO ▲ +2.81% at T+5d
NEUTRAL call +2.81% · α vs SPY +2.95% · entry $26.71 → $27.46
T+1d
+5.50%
call +5.50% · α +5.17%
$28.18
settled 8d ago
T+5d
+2.81%
call +2.81% · α +2.95%
$27.46
settled 4d ago
T+20d
Pending
in 17d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Zenas BioPharma granted 74,900 RSUs to new hires as an inducement material to employment, vesting over four years. This is a routine compensation action with no material financial impact.
Key Facts
- 74,900 RSUs granted to newly hired employees on October 15, 2026
- Vesting in four equal annual installments starting October 15, 2027 through October 15, 2030
- Grant made under Nasdaq Listing Rule 5635(c)(4) as an inducement material to employment
- Subject to continued service through vesting dates
Financial Impact
74,900 RSUs vesting over four years; no dollar value stated
dilution
Risk Factors
- No financial details or market impact from this grant alone
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3382791 |
18 reports for ZBIO
75% Hit rate @ T+60 Went positive at some point 4 of 4 best @ T+60▲ +73.98%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Press Release | $26.71 | awaiting T+60 | — | $27.78 (+4.01%) |
Oct 13, 2026 14d ago | 8-K | $25.16 | awaiting T+60 | — | $27.78 (+10.41%) |
Sep 22, 2026 5w ago | Press Release | $33.05 | awaiting T+60 | — | $27.78 (−15.95%) |
Sep 18, 2026 5w ago | Press Release | $32.55 | awaiting T+60 | — | $27.78 (−14.65%) |
Sep 11, 2026 6w ago | S-3ASR | $31.91 | awaiting T+60 | — | $27.78 (−12.94%) |
May 28, 2026 21w ago | Press Release | $18.56 $32.29 | ▲ +73.98% | ▲ +72.24% | $27.78 (+49.68%) |
May 19, 2026 23w ago | Press Release | $17.84 $29.20 | ▲ +63.68% | ▲ +57.39% | $27.78 (+55.72%) |
May 13, 2026 23w ago | Press Release | $19.93 $32.43 | ▲ +62.72% | ▲ +58.28% | $27.78 (+39.39%) |
May 13, 2026 23w ago | 8-K | $19.93 $32.43 | ▲ +62.72% | ▲ +58.28% | $27.78 (+39.39%) |
May 13, 2026 23w ago | Press Release | $19.93 $32.43 | ▲ +62.72% | ▲ +58.28% | $27.78 (+39.39%) |
Showing 10 of 18
US Market Status
Market Open — Closes in 4h 28m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers